MZ-301

N/A

Report date: 2025/05/23 18:05:42
NME

Base Information

Drug NameMZ-301
Drug Alias NameMZ-301
ClassificationSmall molecules
Mechanisms of ActionApolipoprotein L1 inhibitors
TargetsApolipoprotein L1
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMaze Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaze Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A